The development of personalized medicine, which is based on an individual’s genetic information, is becoming more common in modern healthcare. While some people consider this a major breakthrough, others are concerned about ethical issues and unequal access. In my opinion, although personalized medicine has great potential, its risks must be carefully controlled.
On the one hand, personalized medicine can significantly improve the effectiveness of treatment. Doctors are able to select medicines that are most suitable for a specific patient, which can reduce side effects and increase the chance of recovery. For example, cancer patients can receive targeted therapy based on their genetic profile, leading to better treatment results. As a result, healthcare can become more accurate and efficient.
On the other hand, there are serious ethical concerns and problems related to accessibility. Genetic data is extremely sensitive, and there is a risk that it could be misused by companies or insurance providers. Moreover, personalized treatment is often very expensive, which means that only wealthy people may be able to benefit from it. This could widen the gap between rich and poor and lead to inequality in healthcare.
In conclusion, personalized medicine is a promising advancement that can save lives and improve treatment quality. However, strong regulations are necessary to protect personal data and ensure that such medical services are доступные for everyone, not only for a limited group of people.